Form 4 for SBC SBC Medical Group Holdings Inc
Accepted 2024-09-17 00:00:00 ET · period of report 2024-09-17 · accession 0001213900-24-079606 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-09-17 | 2024-09-17 | SBC | Aikawa Yoshiyuki | COB, CEO, Dir, 10% | J - Other | $0.00 | -1.50M | 92.96M | -2% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock, par value $0.0001 per share | 2024-09-17 | J | D | 1,503,473 | $0.00 | 92,958,960 | D | — | — | (F1) Transfer of 1,503,473 shares pursuant to the terms of that certain Non-Redemption Agreement, dated as of January 11, 2024, among ZUU Target Fund for SBC Medical Group HD Investment Partnership, SBC Medical Group Holdings Incorporated, and Yoshiyuki Aikawa, as amended. |